Sars cov 2 Antigen Rapid Test Kit

Sars cov 2 Antigen Rapid Test Kit

Choices

  • 15-minute speedy detection
  • Simple-to-operate coronavirus antigen check out
  • A lot less-invasive nasal (NS) swab sample assortment
  • CE-IVD marked
  • Accessible in half/5/20 assessments/subject.

Effectivity Traits

JOYSBIO’s coronavirus Ag check out tools was independently evaluated at Centro Diagnostico Delta S.r.l. in Italy between October 2020 and January 2021. An entire of 107 constructive specimens had been examined with JOYSBIO’s COVID-19 Antigen Speedy Test Tools. These specimens had been collected from victims who’re suspected of COVID-19 with nasal swabs. The coronavirus antigen check out tools’s sensitivity and specificity are in distinction in the direction of a CE-IVD marked RT-PCR check out tools. This medical evaluation is carried out beneath the concept that SARS-CoV isn’t spreading regionally. 

Based mostly on the medical analysis of 492 samples, the detection sensitivity is 98.13%, and the specificity is 99.22%.

  • Constructive % Settlement (PPA) = 105/107 (98.13%) (95%CI: 93.4%~99.8%)
  • Antagonistic % Settlement (NPA) = 382/385 (99.22%) (95%CI:97.7%~99.8%)
  • Accuracy = (105+382)/492×100%=98.98%
  • Kappa = 2×(105×382-3×2)/(108×385+107 ×384) = 0.97>0.5

The limit of detection (LOD) of this product is 1.6 x 102 TCID50/mL, calculated by way of a gradient dilution methodology.

Please Observe:

 Underneath listed kits are validated with the talked about batch amount solely. Obligation for batch to batch consistency would not lies with ICMR.
 Minimal acceptance requirements of sensitivity and specificity of Speedy Ag Test Kits:
 Validated as a Stage of Care Test (POCT) with out transport to a laboratory setupSensitivity: 50% and above; Specificity: 95% and above
 Validated in a laboratory setup with samples collected in Viral Transport Medium (VTM)- Sensitivity: 70% and above; Specificity: 99% and above
 Antigen based speedy assessments which can be US-FDA permitted might be utilized instantly after due promoting and advertising and marketing approval from DCGI.

 

In June 2020, JOYSBIO Biotechnology proudly launched a model new COVID-19 Antigen Speedy Test Tools (Colloidal Gold). The model new coronavirus antigen check out tools is a lateral transfer immunoassay for the qualitative detection of SARS-COV-2 antigen (nucleocapsid protein) in larger respiratory samples with nasal swabs or saliva in the midst of the acute part of an an infection. An uncut sheet format is on the market.

 

COVID-19 Antigen Test Course of

  1. Twist off the cap of the buffer bottle, fastidiously dispense all buffer into the extraction tube。 
  2. After accumulating larger respiratory sample with nasal swab, insert the swab into the extraction tube, plunge the swab up and down throughout the fluid for at least 10 seconds. Keep the swab in the direction of the underside of the tube, rotate three turns. DO NOT splash liquid out of the tube. 
  3. Take away the swab whereas squeezing the sides of the tube to extract the liquid from the swab. 
  4. Press the nozzle cap firmly onto the extraction tube. Mix utterly by swirling or flicking the underside of the tube. 
  5. Gently squeeze the tube’s rigid physique, dispense two (2) drops of the buffer-specimen mixture into the sample properly on the coronavirus antigen check out cassette.
  6. Study the check out outcomes between 15 and 20 minutes. Do not study the outcomes after 20 minutes.
sars cov 2 infection
sars cov 2 infection

Key Components

  • This interim guidance is supposed for healthcare suppliers who order antigen assessments, receive antigen check out outcomes, or perform point-of-care testing, along with for laboratory professionals who perform antigen testing in a laboratory setting or on the extent of care and report these outcomes.
  • The intention of this interim technical guidance is to assist environment friendly medical and public nicely being use of antigen assessments for varied testing situations.
  • This guidance applies to all medical and shopper makes use of of antigen assessments and is not specific to any particular age group.
sars cov 2
sars cov 2

Abstract

Background

The Coronavirus sickness 2019 (COVID-19) pandemic continues to unfold internationally. Due to this fact, there’s an urgent need for quick, straightforward, and proper assessments to diagnose excessive acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an an infection. Effectivity traits of the speedy SARS-CoV-2 antigen detection check out must be evaluated and in distinction with the gold customary real-time reverse transcription-polymerase chain response (RT-PCR) check out for prognosis of COVID-19 situations.

Methods

The speedy SARS-CoV-2 antigen detection check out, Customary Q COVID-19 Ag tools (SD Biosensor®, Republic of Korea), was in distinction with the real-time RT-PCR check out, Allplex 2019-nCoV Assay (Seegene®, Korea) for detection of SARS-CoV-2 in respiratory specimens. Four hundred fifty-four respiratory samples (primarily nasopharyngeal and throat swabs) had been obtained from COVID-19 suspected situations and communicate to folks, along with pre-operative victims at Siriraj Hospital, Bangkok, Thailand all through March–Would possibly 2020.

Outcomes

Of 454 respiratory samples, 60 (13.2%) had been constructive, and 394 (86.8%) had been detrimental for SARS-CoV-2 RNA by real-time RT-PCR assay. The size from onset to laboratory check out in COVID-19 suspected situations and communicate to folks ranged from Zero to 14 days with a median of three days. The speedy SARS-CoV-2 antigen detection check out’s sensitivity and specificity had been 98.33% (95% CI, 91.06–99.96%) and 98.73% (95% CI, 97.06–99.59%), respectively. One false detrimental check out consequence was from a sample with a extreme real-time RT-PCR cycle threshold (Ct), whereas 5 false constructive check out outcomes had been from specimens of pre-operative victims.

Newcastle Disease Virus Antigen Rapid Test Kit (Colloidal gold)

abx092016-40tests 40 tests
EUR 432

Human Chlamydia Trachomatis Antigen Rapid Test Kit (Colloidal gold)

abx092049-20tests 20 tests
EUR 230

Melamine (MEL) Rapid Test Kit

abx092057-50tests 50 tests
EUR 370

Clenbuterol (CLE) Rapid Test Kit

abx092058-50tests 50 tests
EUR 244

Ractopamine (RAC) Rapid Test Kit

abx092059-50tests 50 tests
EUR 244

Salbutamol (SAL) Rapid Test Kit

abx092060-50tests 50 tests
EUR 244

Tetracycline (TCs) Rapid Test Kit

abx092063-50tests 50 tests
EUR 398

Sulfonamides (Sas) Rapid Test Kit

abx092064-40tests 40 tests
EUR 398

Quinolones (QNs) Rapid Test Kit

abx092065-40tests 40 tests
EUR 398

Ciprofloxacin (CPFX) Rapid Test Kit

abx092066-50tests 50 tests
EUR 398

Quinolones (QNs) Rapid Test Kit

abx092067-40tests 40 tests
EUR 398

Brucella Antibody Rapid Test Kit

abx092069-40tests 40 tests
EUR 356

Rapid Leishmania Ab Test Kit

RB2104 1 box
EUR 127
Description: Please check the datasheet of Rapid Leishmania Ab Test Kit before using the test.

Rapid PED Ag Test Kit

RG14-01 1 box
EUR 159.9
Description: Please check the datasheet of Rapid PED Ag Test Kit before using the test.

IBD rapid test strip

RG15-04 10 boxes
EUR 148
Description: Please check the datasheet of IBD rapid test strip before using the test.

Rabies rapid test strip

RG18-01 10 boxes
EUR 151.92
Description: Please check the datasheet of Rabies rapid test strip before using the test.

SARS-CoV-2 Antigen Rapid Test Kit (Colloidal gold Immunoassay)

CoV2Ag-25 25 Tests/Kit
EUR 35
Description: This SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold) uses the sandwich immunocapture method and colloidal gold immunochromatography to qualitatively determine the presence of SARS-CoV-2 antigens in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

Avian Influenza H5 Virus Antigen Rapid Test Kit (Colloidal gold)

abx092014-40tests 40 tests
EUR 488

Avian Influenza H7 Virus Antigen Rapid Test Kit (Colloidal gold)

abx092017-40tests 40 tests
EUR 432

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)

IOV87952 20T/kit
EUR 39
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications.

Clenbuterol Rapid Test Kit (Colloidal gold)

abx092040-50tests 50 tests
EUR 272

Ractopamine Rapid Test Kit (Colloidal gold)

abx092042-50tests 50 tests
EUR 300

Salbutamol Rapid Test Kit (Colloidal gold)

abx092043-50tests 50 tests
EUR 342

Chloramphenicol Rapid Test Kit (Colloidal gold)

abx092045-50tests 50 tests
EUR 356

Quinolones Rapid Test Kit (Colloidal gold)

abx092046-50tests 50 tests
EUR 537

Sulfonamides Rapid Test Kit (Colloidal gold)

abx092047-50tests 50 tests
EUR 551

Tetracycline Rapid Test Kit (Colloidal gold)

abx092048-50tests 50 tests
EUR 467

Zearalenone Rapid Test Kit (Colloidal gold)

abx092051-50tests 50 tests
EUR 411

Deoxynivalenol Rapid Test Kit (Colloidal gold)

abx092052-50tests 50 tests
EUR 467

Deoxynivalenol Rapid Test Kit (Colloidal gold)

abx092053-50tests 50 tests
EUR 467

Aflatoxin Rapid Test Kit (Colloidal gold)

abx092054-50tests 50 tests
EUR 398

Zearalenone Rapid Test Kit (Colloidal gold)

abx092056-50tests 50 tests
EUR 425

Goat Brucella Antibody Rapid Test Kit

abx092070-40tests 40 tests
EUR 356

Cow Brucella Antibody Rapid Test Kit

abx092071-40tests 40 tests
EUR 356

Pig Parvovirus Antibody Rapid Test Kit

abx092074-50tests 50 tests
EUR 321

Anigen Rapid FIV Ab Test Kit

RB22-01-DD 10 tests/Kit
EUR 129.8
Description: Please check the datasheet of Anigen Rapid FIV Ab Test Kit before using the test.

Rapid Bovine Brucella Ab Test Kit

RB23-01-DD 1 kit/10 tests
EUR 151.79
Description: Please check the datasheet of Rapid Bovine Brucella Ab Test Kit before using the test.
Share

Leave a Reply

Your email address will not be published.